This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
BT (BT.A.L) - Li Ka-shing's Hutchison Whampoa Ltd has agreed to buy Telefonica's British mobile unit O2 for up to £10.25bn, as Asia's richest man makes his boldest bet yet to revamp his European telecoms business. Closing Price 421.20p (Reuters)
GlaxoSmithKline (GSK.L) - First batch of experimental Ebola vaccine has been shipped to West Africa, expected to arrive in Liberia later on Friday. An initial 300 vials of the vaccine, will be the first to arrive in one of the three main Ebola-affected African countries. 8,641 people have died, according to WHO data. Closing price 1488.50p (Reuters)
Close Brothers Group Plc (CBRO.L) - Shows solid growth, up 4.0% to £5.5bn from 31 July 2014 from £5.3bn. Closing price 1540.00p (Reuters)
Carillion (CLLN.L) - Government awarded two five-year contracts worth around £200m in total to provide facilities management services to its prisons. Closing price 348.00p (Reuters)
Quindell (QPP.L) - The British technology and outsourcing company confirmed it was in exclusive talks with Australian law firm Slater & Gordon Ltd for a possible sale of an operating unit. Closing Price 121.50p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Balfour Beatty | BBY.L | 4.86% | 5.50% | -6.13% |
| DAX 30 | HFD.L | 1.32% | 1.50% | -0.69% |
| UK 100 | DAX.L | 1.02% | 1.19% | -0.03% |
| DOW Jones | DJI.L | 1.48% | 1.63% | -0.41% |
| Royal Mail | RMG.L | 3.91% | 5.49% | 1.30% |
| St James Place | STJ.L | 2.12% | 2.12% | -0.06% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research